Can AMX0035 Be a Potential Game Changer in ALS?
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) is a clinical-stage biotechnology Company is focussed on creating novel therapeutics for the treatment of neurodegenerative diseases such as ALS and Alzheimer’s. The Company is awaiting the decision on its NDA for AMX0035 (sodium phenylbutyrate (PB) and taurursodiol (TURSO; also...
